Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bilin
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Women's Pharmacy
- Administration
- Oral
01
Overview
Bilin (also known as Milin) is an approved traditional Chinese medicine (specifically a Miao ethnic medicine) developed by Guizhou Yibai Women's Pharmacy (a subsidiary of Guizhou Yibai Pharmaceutical). It is formulated as both capsules and granules. Bilin is composed of four herbal ingredients: *Polygonum capitatum* (头花蓼), *Plantago asiatica* (车前草), *Oxalis corniculata* (酢浆草), and *Boenninghausenia albiflora* (石椒草). It is primarily indicated for clearing heat, detoxifying, and promoting diuresis to treat urinary tract infections, painful urination, and damp-heat accumulation in the urinary system.
- Brand names
- Yibai
- Other names
- Bi LinBi Lin CapsulesBilin capsuleBilin granuleMilinMilin capsuleMilin granule泌淋泌淋胶囊泌淋颗粒
Beyond the preview
Go deeper on Bilin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bilin.